These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26857534)

  • 1. Breast cancer stem cells phenotype and plasma cell-predominant breast cancer independently indicate poor survival.
    Wei H; Fu P; Yao M; Chen Y; Du L
    Pathol Res Pract; 2016 Apr; 212(4):294-301. PubMed ID: 26857534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer.
    Polónia A; Pinto R; Cameselle-Teijeiro JF; Schmitt FC; Paredes J
    J Clin Pathol; 2017 Oct; 70(10):860-867. PubMed ID: 28373294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab.
    Lee HJ; Kim JY; Park IA; Song IH; Yu JH; Ahn JH; Gong G
    Am J Clin Pathol; 2015 Aug; 144(2):278-88. PubMed ID: 26185313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.
    Pruneri G; Gray KP; Vingiani A; Viale G; Curigliano G; Criscitiello C; Láng I; Ruhstaller T; Gianni L; Goldhirsch A; Kammler R; Price KN; Cancello G; Munzone E; Gelber RD; Regan MM; Colleoni M
    Breast Cancer Res Treat; 2016 Jul; 158(2):323-31. PubMed ID: 27372069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of T lymphocytes infiltration in breast cancer].
    Yu HM; Jiao SC; Yang JL; Wang JD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):199-206. PubMed ID: 23643010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
    Chen Y; Song J; Jiang Y; Yu C; Ma Z
    Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH(+)/CD44(+) cells in breast cancer are associated with worse prognosis and poor clinical outcome.
    Qiu Y; Pu T; Guo P; Wei B; Zhang Z; Zhang H; Zhong X; Zheng H; Chen L; Bu H; Ye F
    Exp Mol Pathol; 2016 Feb; 100(1):145-50. PubMed ID: 26687806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.
    Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J
    Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis.
    Ibrahim EM; Al-Foheidi ME; Al-Mansour MM; Kazkaz GA
    Breast Cancer Res Treat; 2014 Dec; 148(3):467-76. PubMed ID: 25361613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes.
    Kim JY; Heo SH; Choi SK; Song IH; Park IA; Kim YA; Park HS; Park SY; Bang WS; Gong G; Lee HJ
    Virchows Arch; 2017 Apr; 470(4):381-389. PubMed ID: 28185053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer.
    Bernardi MA; Logullo AF; Pasini FS; Nonogaki S; Blumke C; Soares FA; Brentani MM
    Oncol Rep; 2012 Jan; 27(1):28-38. PubMed ID: 21956537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.
    Matsumoto H; Thike AA; Li H; Yeong J; Koo SL; Dent RA; Tan PH; Iqbal J
    Breast Cancer Res Treat; 2016 Apr; 156(2):237-47. PubMed ID: 26960711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of CD3+ tumor infiltrating lymphocytes is significantly associated with good prognosis in infiltrating ductal carcinoma of breast.
    Rathore AS; Kumar S; Konwar R; Srivastava AN; Makker A; Goel MM
    Indian J Cancer; 2013; 50(3):239-44. PubMed ID: 24061465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas.
    Schalper KA; Velcheti V; Carvajal D; Wimberly H; Brown J; Pusztai L; Rimm DL
    Clin Cancer Res; 2014 May; 20(10):2773-82. PubMed ID: 24647569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of tumor lymphocyte infiltration with clinicopathological factors and survival in breast cancer.
    Huszno J; Nożyńska EZ; Lange D; Kołosza Z; Nowara E
    Pol J Pathol; 2017; 68(1):26-32. PubMed ID: 28547977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma.
    Vassilakopoulou M; Avgeris M; Velcheti V; Kotoula V; Rampias T; Chatzopoulos K; Perisanidis C; Kontos CK; Giotakis AI; Scorilas A; Rimm D; Sasaki C; Fountzilas G; Psyrri A
    Clin Cancer Res; 2016 Feb; 22(3):704-13. PubMed ID: 26408403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer.
    Yeong J; Lim JCT; Lee B; Li H; Chia N; Ong CCH; Lye WK; Putti TC; Dent R; Lim E; Thike AA; Tan PH; Iqbal J
    Front Immunol; 2018; 9():1209. PubMed ID: 29899747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study.
    Wang YQ; Chen YP; Zhang Y; Jiang W; Liu N; Yun JP; Sun Y; He QM; Tang XR; Wen X; Yang XJ; Zhang PP; Zhang J; Lei Y; Li YQ; Ma J
    Int J Cancer; 2018 Jun; 142(12):2558-2566. PubMed ID: 29377121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of preoperative short course famotidine on TILs and survival in breast cancer.
    Parshad R; Hazrah P; Kumar S; Gupta SD; Ray R; Bal S
    Indian J Cancer; 2005; 42(4):185-90. PubMed ID: 16391436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    In Vivo; 2018; 32(1):151-158. PubMed ID: 29275313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.